Starting from October 3 this year, subjects in the second phase of booster vaccination with Moderna next-generation bivalent vaccine will be available, and there should be at least 12 weeks (84 days) between the last basic dose/basic booster dose or the previous booster dose. .

(provided by the command center)

[Reporter Wu Liangyi/Taipei Report] In response to the local epidemic of Wuhan pneumonia (new coronavirus disease, COVID-19), the Central Epidemic Command Center announced today that starting from October 3 this year, the second phase of the additional vaccination of Modena will be opened. Generations of bivalent vaccines should be at least 12 weeks (84 days) apart from the last basal/basal booster dose or the previous booster dose.

In the second stage, the open objects are as follows: 1. Medical personnel.

2. Staff related to airports, ports, home quarantine, aviation crews/crews, and staff related to institutions and social welfare care systems.

3. Adults aged 50 to 64 years old.

4. Those over the age of 18 who need to go abroad for diplomatic, official, business negotiation and other work needs.

Please read on...

The command center reminds that the open objects include people over the age of 18 who need to go abroad due to work needs such as diplomacy, official business, and business negotiations. Bring the invitation certificate of the inviting unit, the approval letter from the competent authority of the target business or the company's approval to go abroad (1 out of 3), and the air ticket for the inoculation unit to verify the identity.

In addition, after vaccination, you can join the Taiwan V-Watch Vaccination-Health Report by scanning the instructions provided by the vaccination unit or the QR code on the poster. By observing the status after vaccination, you can remind you to seek medical treatment and understand the common discomfort after vaccination.

The command center once again appealed that vaccination can reduce the risk of severe illness and death after infection, and according to clinical trials, bivalent vaccines containing the original strain and BA.1 variant strain are more resistant to Omicron variant strains than monovalent vaccines. good protection.

At present, the first phase of the target has been opened, including the elderly over 65 years old, residents of long-term care institutions, and those over 18 years old who are immunocompromised and immunocompromised. Evaluation, complete bivalent vaccine booster vaccination as soon as possible.

For related news, see:

"Wuhan Pneumonia Zone", please click here, more relevant information will bring you first-hand grasp.